Application of organoids in spinal cord injury, brain ischemia and traumatic brain injury
Nature Advance · 31.03.2026
DOI: 10.61958/nazs3952 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature Advance, online erschienen am 31.03.2026. Verfasst von Qi-Qin Dan. Die Arbeit nennt 70 Literaturangaben.
Abstract (Originalsprache)
Spinal cord injury (SCI), brain ischemia (BI), and traumatic brain injury (TBI) are major causes of mortality and long-term neurological disability worldwide, yet effective therapeutic strategies remain limited. A key barrier to progress lies in the lack of experimental models that faithfully recapitulate the structural complexity, cellular heterogeneity, and human-specific pathological features of central nervous system (CNS) injuries. Organoid technology has recently emerged as a promising platform to address these challenges. Derived from stem cells, organoids enable the reconstruction of three-dimensional (3D) neural tissues that partially mimic in vivo cytoarchitecture and functional properties, thereby providing new opportunities for studying CNS injury and repair. In this review, we synthesize current advances in the application of organoid-based models in SCI, BI, and TBI, with a focus on three key areas: strategies for organoid generation and disease modeling, the recapitulation of core pathological processes, and their use in evaluating therapeutic interventions. Recent studies demonstrate that organoids can reproduce critical aspects of CNS injury, including neuronal loss, neuroinflammation, axonal degeneration, and blood–brain barrier disruption, while also serving as versatile platforms for testing emerging therapies such as cell-based approaches, biomaterial-assisted repair, and pharmacological interventions. Nevertheless, important limitations persist, including incomplete maturation, insufficient vascularization, and challenges in standardization and reproducibility. Overall, organoid-based models represent a rapidly evolving and transformative approach in CNS research. Continued methodological refinement and integration with advanced technologies are expected to enhance their physiological relevance and accelerate their translation into clinical applications.
Zitieren
APA
Dan, Q. (2026). Application of organoids in spinal cord injury, brain ischemia and traumatic brain injury. Nature Advance. https://doi.org/10.61958/nazs3952
Vancouver
Dan Q. Application of organoids in spinal cord injury, brain ischemia and traumatic brain injury. Nature Advance. 2026. doi:10.61958/nazs3952
BibTeX
@article{Dan2026,
author = {Dan, Qi-Qin},
title = {Application of organoids in spinal cord injury, brain ischemia and traumatic brain injury},
journal = {Nature Advance},
year = {2026},
doi = {10.61958/nazs3952}
}
EUVIMED